Sector
Vaaka Partners exits Nab Labs
Vaaka Partners, formerly Pohjola Capital Partners, and Inveni Capital have sold their stakes in Nab Labs.
3i sale of Hyva enters second round
3i’s sale of Dutch hydraulic cylinder producer Hyva has entered the second round, with private equity firms and trade buyers among the bidders, according to reports.
VantagePoint and Sustainable Technologies invest in REAC
VantagePoint and Sustainable Technologies Fund have, alongside oil company BP, invested $4.5m in Swedish cleantech company REAC Fuel.
Swedish PE-firms facing tax investigation
Skatteverket, the Swedish Tax Office, has launched an investigation into the declaration of tax by eight of the largest Swedish private equity firms, according to reports.
Consortium set to list Zealand Pharma
A consortium, consisting of Life Sciences Partners and Sunstone Capital among others, has announced its intention to list Zealand Pharma A/S on the NASDAQ OMX Copenhagen.
Suanfarma sells Halotech to ST Technologies
Suanfarma has exited biotechnology company Halotech DNA via a trade sale to Sexing Technologies, a business that specialises in the gender identification of beef-cattle semen.
Permira among bidders for Dometic
Permira is among the bidders for Dometic, a producer of leisure products for the caravan and motor home industry, according to reports.
AXA PE acquires 11% of Arismore
AXA Private Equity has taken an 11% stake in French IT services company Arismore for an undisclosed amount.
Citi looks to sell $500m of private equity holding
Citigroup is looking to sell $500m of private equity investments made with CVC Capital Partners, according to reports.
Kernel Capital and IIU inject €2m in Decawave
Kernel Capital and International Investment & Underwriting (IIU) have invested тЌ2m in Irish semiconductor company Decawave.
PAI buys Swissport for €654m
Private equity firm PAI Partners has bought passenger and cargo handling company Swissport from Spanish infrastructure group Ferrovial for €654m.
ARX invests in Bochemie Group
ARX Equity Partners has taken a minority stake in Czech chemicals company Bochemie Group.
Cognetas buys Arcaplanet from Credem
Cognetus has purchased Arcaplanet from Credem Private Equity in a deal which represents the private equity firm’s first investment for more than two years.
Suanfarma launches €30m biotech fund
Specialist investor Suanfarma is to launch its second private equity fund, which will target companies working within the biotechnology sector in Spain.
Sovereign Capital funds fifth add-on for NFA Partnerships
Buy-and-build specialist Sovereign Capital has committed new equity to fund a fifth add-on acquisition for its portfolio firm National Fostering Agency Partnerships (NFAP).
Caja Navarra invests in Nanobiomatters
The private equity arm of Corporación Caja Navarra has acquired a 17% stake in Nanobiomatters, a material science company specialising in nanoclay-based additives.
Waterland acquires Ranger in LBO
Waterland Private Equity has acquired Ranger Marketing & Vertriebs in an LBO designed to fund the company’s expansion into other countries and business areas.
ALMI and K-Svets invest SEK 6m in Bluetest
ALMI Invest and K-Svets Ventures have completed a SEK 6m funding round in Bluetest AB.
Aescap Venture, De Hoge Dennen and Jeroen Cammeraat invest in i-Optics
Aescap Venture, De Hoge Dennen and private investor Jeroen Cammeraat have invested €4.2m in i-Optics.
Oaktree lifts Beluga Shipping with major investment
Oaktree Capital Management has committed €200m to support the German operator of heavy-lift vessels Beluga Shipping.
3i mulls sale of Fairlane
3i may be looking to sell boat manufacturer Fairlane, which it failed to offload two years ago, according to reports.
AXA PE invests €150m in KOS
AXA Private Equity is to invest €150m in KOS, the health services unit of Compagnie Industriali Riunite (CIR), increasing its stake in the firm to 47%.
Ares Life Sciences to take Stallergenes private
Ares Life Sciences has agreed to buy 45.6% of listed French biopharma Stallergenes from Wendel, and plans to file a mandatory takeover offer for all the remaining shares.
Vendis Capital invests in Eyes and More
Vendis Capital has reached an agreement to invest up to €12m in Dutch optical chain Eyes and More.